venerdì 22 maggio 2020

FDA Approves Olaparib for HRR Gene-Mutated Metastatic Castration Resistant Prostate Cancer - FDA also approved companion diagnostic devices for selection of patients

Fonte: ESMO European Society for Medical Oncology

Link all'articolo completo